Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma
Authors:
- Helger StegeHSHelger Stege
- Mossaad MegahedMMMossaad Megahed
- Thomas RuzickaTRThomas Ruzicka
- Yuko HosokawaYHYuko Hosokawa
- Takuo TsujiTTTakuo Tsuji
- Akimichi MoritaAMAkimichi Morita
- Jean KrutmannJKJean Krutmann
- 1 July 1999
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 41 (1) , 47-50
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- UVA1 Radiation Triggers Two Different Final Apoptotic PathwaysJournal of Investigative Dermatology, 1999
- A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitisImmunology Today, 1998
- High-dose UVA1 therapy for atopic dermatitis: Results of a multicenter trialJournal of the American Academy of Dermatology, 1998
- Evidence that Singlet Oxygen-induced Human T Helper Cell Apoptosis Is the Basic Mechanism of Ultraviolet-A Radiation PhototherapyJournal of Experimental Medicine, 1997
- High-dose UVA1 radiation therapy for localized sclerodermaJournal of the American Academy of Dermatology, 1997
- Apoptosis Induction by Ultraviolet Light A and Photochemotherapy in Cutaneous T-Cell Lymphoma: Relevance to Mechanism of Therapeutic ActionJournal of Investigative Dermatology, 1996
- PUVA Treatment Selectively Induces a Cell Cycle Block and Subsequent Apoptosis in Human T‐LymphocytesPhotochemistry and Photobiology, 1996
- High-dose UVA1 for urticaria pigmentosaThe Lancet, 1996
- Low dose versus medium dose UV-A1 treatment in severe atopic eczema.Acta Dermato-Venereologica, 1995
- The Optics of Human SkinJournal of Investigative Dermatology, 1981